Indications and uses
reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.
reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.
■ shake well before using ■ use only with enclosed dosing cup adults and children 12 years of age and over take 10 mL every 12 hours; do not take more than 20 mL in 24 hours children 6 to under 12 years of age take 5 mL every 12 hours; do not take more than 10 mL in 24 hours children under 6 years of age ask a doctor adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor Note: mL=...
Children’s Allegra Hives 12 HR oral suspension - Grape Flavor
Drug Facts
(in each 5 mL)
Fexofenadine HCl 30 mg
Antihistamine
reduces hives and relieves itching due to hives (urticaria).
This product will not prevent hives or an allergic skin reaction from occurring.
Severe Allergy Warning: Get emergency help immediately if you have hives along with any of the following symptoms: ■ swelling of tongue ■ trouble swallowing ■ swelling in or around mouth ■ trouble speaking
■ wheezing or problems breathing ■ drooling ■ dizziness or loss of consciousness
These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health professional immediately. Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later.
Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrine injector for “anaphylaxis” or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times.
■ to prevent hives from any known cause such as:
■ foods ■ insect stings ■ medicines ■ latex or rubber gloves
because this product will not stop hives from occurring.
Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not
know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a
cause.
■ if you have ever had an allergic reaction to this product or any of its ingredients
■ kidney disease. Your doctor should determine if you need a different dose.
■ hives that are an unusual color, look bruised or blistered
■ hives that do not itch
■ do not take more than directed
■ do not take at the same time as aluminum or magnesium antacids
■ do not take with fruit juices (see Directions)
■ an allergic reaction to this product occurs. Seek medical help right away.
■ symptoms do not improve after 3 days of treatment
■ the hives have lasted more than 6 weeks
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
■ shake well before using ■ use only with enclosed dosing cup
| adults and children 12 years of age and over | take 10 mL every 12 hours; do not take more than 20 mL in 24 hours |
| children 6 to under 12 years of age | take 5 mL every 12 hours; do not take more than 10 mL in 24 hours |
| children under 6 years of age | ask a doctor |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
| Note: mL= milliliters | |
■ each 5 mL contains: potassium 5 mg and sodium 19 mg
■ safety sealed: do not use if carton is opened or if printed foil inner seal on bottle is torn or missing
■ store between 20º and 25ºC (68º and 77ºF)
■ color change from white to beige is expected over time. This does not impact product effectiveness and safety.
edetate disodium, flavor, poloxamer 407, potassium sorbate, propylene glycol, purified water, sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, sucrose, titanium dioxide, xanthan gum, xylitol
call 1-8 66 - 844 - 2798
NDC 41167-4227-1
Childrens Allegra Hives
Grape Flavor
30 mg/5 mL antihistamine
Grape
12 HR
240 mL
| Class | Version | Type | Effective |
|---|---|---|---|
| FEXOFENADINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-4227-1 | Childrens Allegra Hives | 1 in 1 CARTON | SUSPENSION | 1 | 1 | |
| 41167-4227-1 | Childrens Allegra Hives | 240 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 240 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-4227 | 41167-4227-1 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N201373-001 | CHILDREN'S ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | |
| N201373-002 | CHILDREN'S ALLEGRA HIVES | FEXOFENADINE HYDROCHLORIDE | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | |
| N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SUSPENSION / ORAL | RLD | 2011-01-24 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML | SUSPENSION / ORAL | RLD | 2011-01-24 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML | SUSPENSION / ORAL | RLD | 2011-01-24 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N201373-001 | CHILDREN'S ALLEGRA ALLERGY | 30MG/5ML | SUSPENSION / ORAL | RLD, RS | 2011-01-24 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N201373-002 | CHILDREN'S ALLEGRA HIVES | 30MG/5ML | SUSPENSION / ORAL | RLD | 2011-01-24 | 74a2ff9319b5… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N201373-002 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N201373-001 | 8933097 | 2030-08-02 | Drug product | 2015-02-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N201373-002 | 8933097 | 2032-08-16 | Drug product | 2015-02-19 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Allegra Hives | FEXOFENADINE HCL | Chattem, Inc. | ff50d9cd-d849-43e8-b32a-4dcde798d3eb | 2026-05-01 | Warnings | 41167-4227-1 41167-4227 41167422701 37df2ad5-479f-4534-b550-e42479a3b2db ff50d9cd-d849-43e8-b32a-4dcde798d3eb |
Adverse event summaries are temporarily unavailable. Other product information remains available.